Fed. Circ. Backs Celgene Win In Teva Cancer Drug Patent Suit
The Federal Circuit ruled Wednesday that a lower court correctly construed the claims of a Teva Pharmaceutical Industries Ltd. unit's patent on a drug used to treat breast cancer, leaving in...To view the full article, register now.
Already a subscriber? Click here to view full article